Fresenius Medical Care AG
FMS
$22.06
-$0.04-0.18%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.80% | 6.10% | 4.05% | 1.08% | -0.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.80% | 6.10% | 4.05% | 1.08% | -0.96% |
| Cost of Revenue | 4.67% | 4.61% | 4.20% | 1.97% | 0.31% |
| Gross Profit | 13.38% | 10.67% | 3.59% | -1.54% | -4.70% |
| SG&A Expenses | 4.48% | 0.83% | -0.15% | -0.90% | -3.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 72.49% | 68.31% | 76.15% | -3.98% | -113.43% |
| Total Operating Expenses | 4.90% | 4.23% | 3.85% | 1.20% | -0.86% |
| Operating Income | 28.66% | 27.62% | 6.16% | -0.25% | -2.14% |
| Income Before Tax | 37.15% | 50.45% | -0.09% | 9.34% | 12.84% |
| Income Tax Expenses | -3.90% | 6.51% | -17.44% | 2.18% | 13.54% |
| Earnings from Continuing Operations | 54.24% | 69.19% | 6.65% | 12.28% | 12.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -22.89% | -10.43% | 12.17% | 18.60% | 17.59% |
| Net Income | 64.06% | 91.29% | 12.94% | 25.83% | 27.10% |
| EBIT | 28.66% | 27.62% | 6.16% | -0.25% | -2.14% |
| EBITDA | 16.13% | 14.34% | 2.31% | -2.06% | -2.97% |
| EPS Basic | 67.11% | 93.25% | 13.15% | 25.83% | 27.11% |
| Normalized Basic EPS | 39.19% | 44.77% | 22.04% | 14.73% | 9.30% |
| EPS Diluted | 67.70% | 94.23% | 12.88% | 25.55% | 26.81% |
| Normalized Diluted EPS | 39.19% | 44.77% | 22.04% | 14.73% | 9.30% |
| Average Basic Shares Outstanding | -2.30% | -0.75% | -0.11% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -2.30% | -0.75% | -0.11% | 0.00% | 0.00% |
| Dividend Per Share | 13.00% | 13.00% | 19.82% | 19.82% | 19.82% |
| Payout Ratio | -0.22% | -0.33% | 0.13% | 0.01% | -0.17% |